WCN26-2683 Identification of antineoplastic agents associated with worsening proteinuria and impact of baseline proteinuria on its progression

Read full text Summarise with VIRAT
Authors: Norihiro Kobayashi, Miho Murashima, Shohei Manabe, Nobutaka Okada, Yoshihisa Nakatani, Shuji Arima
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

In patients with malignant neoplasms, the development of significant proteinuria can lead to interruption of treatment. More recently, urinary loss of therapeutic antibodies with consequent reductions in circulating drug concentrations has been recognized, potentially necessitating modifications to treatment plans.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Multiple Myeloma Research and Treatments Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104153–104153
Publication date
25 March 2026
Language
EN